Attached files

file filename
10-K - FORM 10-K - QUESTCOR PHARMACEUTICALS INCd275255d10k.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(B)/15D-14(B) - QUESTCOR PHARMACEUTICALS INCd275255dex322.htm
EX-32.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(B)/15D-14(B) - QUESTCOR PHARMACEUTICALS INCd275255dex321.htm
EX-23.2 - CONSENT OF BDO USA, LLC - QUESTCOR PHARMACEUTICALS INCd275255dex232.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)/15D-14(A) - QUESTCOR PHARMACEUTICALS INCd275255dex311.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)/15D-14(A) - QUESTCOR PHARMACEUTICALS INCd275255dex312.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-134879, 333-114166, 333-102988, 333-85160, 333-61866, 333-25661, 333-32159, 333-23085, 333-17501, 333-03507, and 333-107755) and the Registration Statements on Form S-8 (Nos. 333-116624, 333-30558, 333-46990, 333-81243, 333-105694, 333-105693, 333-134878, and 333-151395), pertaining to the 1992 Stock Option Plan, the 1993 Non-Employee Directors’ Equity Incentive Plan, the 2000 Employee Stock Purchase Plan, the 2003 Employee Stock Purchase Plan, the 2004 Non-Employee Directors’ Equity Incentive Plan and the 2006 Equity Incentive Award Plan of Questcor Pharmaceuticals, Inc. of our report dated February 22, 2011, with respect to the consolidated financial statements and schedule of Questcor Pharmaceuticals, Inc. for the years ended December 31, 2010 and 2009, included in this Annual Report on Form 10-K for the year ended December 31, 2011.

/s/ OUM & Co. LLP

San Francisco, California

February 20, 2011